Unknown

Dataset Information

0

Clinical, Diagnostic and Prognostic Characteristics of Primary Cutaneous Gamma Delta T-cell Lymphomas.

ABSTRACT: Primary cutaneous γδ T-cell lymphoma (PCGDTL) is a rare subtype of non-Hodgkin lymphoma (NHL) that arises from T-cells with γδ T-cell receptors. The exact incidence of PCGDTL is unknown, as it is usually lumped with other cutaneous lymphomas, which are also uncommon. It is one of the peripheral T-cell lymphoma (PTCL) subtypes which is known to have a dismal prognosis due to poor response and the paucity of available therapies. Despite the rarity and uncertainties of PCGDTL, a number of studies over the past decade were published about the pathologic, diagnostic, cytogenetic and clinical features of this disease. These diagnostic advances will open the doors to explore new therapeutics for this rare entity, specifically targeted and immune therapies. In this review, we highlight these advances, summarize the contemporary treatment approaches, and shed the light on future potential therapeutic targets.

SUBMITTER: Muhsen IN 

PROVIDER: S-EPMC9358781 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Clinical, Diagnostic and Prognostic Characteristics of Primary Cutaneous Gamma Delta T-cell Lymphomas.

Muhsen Ibrahim N IN   El Fakih Riad R   Hamadani Mehdi M   Lazarus Hillard M HM   Kharfan-Dabaja Mohamed A MA   Aljurf Mahmoud M  

Clinical hematology international 20220622 1-2

Primary cutaneous <i>γδ</i> T-cell lymphoma (PCGDTL) is a rare subtype of non-Hodgkin lymphoma (NHL) that arises from T-cells with <i>γδ</i> T-cell receptors. The exact incidence of PCGDTL is unknown, as it is usually lumped with other cutaneous lymphomas, which are also uncommon. It is one of the peripheral T-cell lymphoma (PTCL) subtypes which is known to have a dismal prognosis due to poor response and the paucity of available therapies. Despite the rarity and uncertainties of PCGDTL, a numbe  ...[more]

Similar Datasets

Unknown Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas.
| S-EPMC7156460 | biostudies-literature
Unknown TG1042 (Adenovirus-interferon-γ) in primary cutaneous B-cell lymphomas: a phase II clinical trial.
| S-EPMC3933342 | biostudies-literature
Unknown Clinical characteristics and prognostic factors of bone lymphomas: focus on the clinical significance of multifocal bone involvement by primary bone large B-cell lymphomas.
| S-EPMC4265495 | biostudies-literature
Unknown Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas.
| S-EPMC2889748 | biostudies-literature
Unknown Skin-directed radiotherapy for primary cutaneous T-cell lymphomas.
| S-EPMC11467483 | biostudies-literature
Unknown MicroRNA profiling of primary cutaneous large B-cell lymphomas.
| S-EPMC3865085 | biostudies-literature
Unknown A Rare Case of Primary Cutaneous Gamma-Delta T-cell Lymphoma with Aberrant B-cell Marker Expression.
| S-EPMC10593491 | biostudies-literature
Genomics Addiction of primary cutaneous gamma-delta T-cell lymphomas to JAK-STAT signaling
| PRJNA1184839 | ENA
Genomics Addiction of primary cutaneous gamma-delta T-cell lymphomas to JAK-STAT signaling
| PRJNA1184840 | ENA
Unknown Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators.
| S-EPMC5468001 | biostudies-literature